Literature DB >> 8137828

An autonomous N-terminal transactivation domain in Fos protein plays a crucial role in transformation.

K U Jooss1, M Funk, R Müller.   

Abstract

To date, three functional domains have been defined in c-Fos and v-Fos proteins and have been shown to play a role in transactivation: the leucine zipper mediating hetero-dimerization, the basic DNA contact site, and a C-terminally located transactivation domain (C-TA) harbouring the HOB1 and HOB2 motifs. While the bZip region, consisting of the leucine zipper and the DNA contact site, is indispensable for transformation, the C-TA domain is not required and is actually altered by internal deletions in the FBR-MuSV. We now show that the N-terminal regions of c-Fos and v-Fos contain a second transactivation domain (N-TA). A functionally crucial motif within the N-TA domain, termed NTM, was pinpointed to a approximately 25 amino acid stretch around positions 60-84 which is highly conserved in FosB. Analysis of LexA fusion proteins showed that the N-TA domains of both c-Fos and FosB function in an autonomous fashion in both fibroblasts and yeast. Most importantly, deletion of the NTM motif impairs the transforming properties of v-Fos. Apart from the bZip region, the N-TA domain is the only functional domain required for transformation by v-Fos, at least when its expression is driven by the strong FBR-MuSV-LTR promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137828      PMCID: PMC394966          DOI: 10.1002/j.1460-2075.1994.tb06401.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins.

Authors:  D Mumberg; F C Lucibello; M Schuermann; R Müller
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

Review 2.  Proto-oncogenes encoding transcriptional regulators: unravelling the mechanisms of oncogenic conversion.

Authors:  F C Lucibello; R Müller
Journal:  Crit Rev Oncog       Date:  1991

3.  Extended life span and tumorigenicity of nonestablished mouse connective tissue cells transformed by the fos oncogene of FBR-MuSV.

Authors:  T Jenuwein; D Müller; T Curran; R Müller
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

4.  Constitutive expression of FosB and its short form, FosB/SF, induces malignant cell transformation in rat-1A cells.

Authors:  K Kovary; C A Rizzo; R P Ryseck; T Noguchi; C Raynoschek; J M Pelosin; R Bravo
Journal:  New Biol       Date:  1991-09

5.  Fos is phosphorylated by p34cdc2, cAMP-dependent protein kinase and protein kinase C at multiple sites clustered within regulatory regions.

Authors:  C Abate; D R Marshak; T Curran
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

6.  Multiple regions of v-Fos protein involved in the activation of AP1-dependent transcription: is trans-activation crucial for transformation?

Authors:  F C Lucibello; M Neuberg; T Jenuwein; R Müller
Journal:  New Biol       Date:  1991-07

7.  fosB is a transforming gene encoding a transcriptional activator.

Authors:  M Schuermann; K Jooss; R Müller
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

8.  Mutagenesis of the DNA contact site in Fos protein: compatibility with the scissors grip model and requirement for transformation.

Authors:  M Neuberg; M Schuermann; R Müller
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

9.  Phosphorylation of c-jun mediated by MAP kinases.

Authors:  B J Pulverer; J M Kyriakis; J Avruch; E Nikolakaki; J R Woodgett
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

10.  Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.

Authors:  T Smeal; B Binetruy; D A Mercola; M Birrer; M Karin
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

View more
  16 in total

1.  Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.

Authors:  Guillaume Bossis; Cécile E Malnou; Rosa Farras; Elisabetta Andermarcher; Robert Hipskind; Manuel Rodriguez; Darja Schmidt; Stefan Muller; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

2.  CTF5--a new transcriptional activator of the NFI/CTF family.

Authors:  S Wenzelides; H Altmann; W Wendler; E L Winnacker
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

3.  LexA chimeras reveal the function of Drosophila Fos as a context-dependent transcriptional activator.

Authors:  D Szüts; M Bienz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression.

Authors:  D Mumberg; R Müller; M Funk
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

5.  A novel, transformation-relevant activation domain in Fos proteins.

Authors:  M Funk; B Poensgen; W Graulich; V Jerome; R Müller
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

6.  The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.

Authors:  K McBride; M Nemer
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity.

Authors:  George Sabatakos; Glenn C Rowe; Marie Kveiborg; Meilin Wu; Lynn Neff; Riccardo Chiusaroli; William M Philbrick; Roland Baron
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741

8.  AP1 genes in Fugu indicate a divergent transcriptional control to that of mammals.

Authors:  Amanda J Cottage; Yvonne J K Edwards; Greg Elgar
Journal:  Mamm Genome       Date:  2003-08       Impact factor: 2.957

9.  Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice.

Authors:  Glenn C Rowe; Cheol Soo Choi; Lynn Neff; William C Horne; Gerald I Shulman; Roland Baron
Journal:  Endocrinology       Date:  2008-09-04       Impact factor: 4.736

10.  Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells.

Authors:  O Kustikova; D Kramerov; M Grigorian; V Berezin; E Bock; E Lukanidin; E Tulchinsky
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.